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Background. Necrotizing enterocolitis (NEC) is a devastating inﬂammatory bowel disease of premature infants
speculatively associated with infection. Suspected NEC can be indistinguishable from sepsis, and in established cases
an infant may die within hours of diagnosis. Present treatment is supportive. A means of presymptomatic diagnosis
is urgently needed. We aimed to identify microbial signatures in the gastrointestinal microbiota preceding NEC di-
agnosis in premature infants.
Methods. Fecal samples and clinical data were collected from a 2-year cohort of 369 premature neonates. Next-
generation sequencing of 16S ribosomal RNA gene regions was used to characterize the microbiota of prediagnosis
fecal samples from 12 neonates with NEC, 8 with suspected NEC, and 44 controls. Logistic regression was used to
determine clinical characteristics and operational taxonomic units (OTUs) discriminating cases from controls. Sam-
ples were cultured and isolates identiﬁed using matrix-assisted laser desorption/ionization–time of ﬂight. Clostridial
isolates were typed and toxin genes detected.
Results. A clostridial OTU was overabundant in prediagnosis samples from infants with established NEC
(P = .006). Culture conﬁrmed the presence of Clostridium perfringens type A. Fluorescent ampliﬁed fragment-length
polymorphism typing established that no isolates were identical. Prediagnosis samples from NEC infants not carry-
ing profuse C. perfringens revealed an overabundance of a Klebsiella OTU (P = .049). Prolonged continuous positive
airway pressure (CPAP) therapy with supplemental oxygen was also associated with increased NEC risk.
Conclusions. Two fecal microbiota signatures (Clostridium and Klebsiella OTUs) and need for prolonged CPAP
oxygen signal increased risk of NEC in presymptomatic infants. These biomarkers will assist development of a
screening tool to allow very early diagnosis of NEC.
Clinical Trials Registration. NCT01102738.
Keywords. necrotizing enterocolitis; NEC; fecal microbiota; premature infant.
Necrotizing enterocolitis (NEC) is a devastating disease
primarily affecting premature infants, with an incidence
increasing with lower gestational age. Remarkable pro-
gress in neonatal intensive care over the past 2 decades
has enabled the survival of increasingly premature, vul-
nerable babies, but with this comes an increase in cases
of NEC [1]. NEC has a high mortality—up to 35% in
extremely low-birth-weight infants (<1000 g) [2]—and
in survivors, gastrointestinal (GI) dysfunction and func-
tional impairment may be lifelong [3].
A strategy for surveillance/screening is essential to re-
duce the impact of this condition, for the timely diag-
nosis of NEC is difﬁcult. Using Bell staging [4], the
earliest signs (Bell stage 1 [suspected NEC]) are indis-
tinguishable from sepsis (bloodstream infection). In
cases when NEC has been conﬁrmed (Bell stages 2 [def-
inite] and 3 [severe]), clinical deterioration may be so
rapid that the infant dies within hours of diagnosis. Al-
though the Bell staging system is useful for grouping
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signs and symptoms, it does not address etiology [5]. Despite
>1.5 centuries of research [6], the cause of this inﬂammatory
bowel disease remains elusive, and treatment strategies remain
largely supportive and nonspeciﬁc.
NEC is thought to be a multifactorial disease requiring an im-
mature gut, enteral feeds, and bacterial colonization for its de-
velopment [7]. Evidence supporting the contribution of an
infectious agent stems from well-documented outbreaks [8];
an association between empirical use of antibiotics in the ﬁrst
week of life and an increased risk of NEC [9], possibly due to
the potential distortion of the GI microbiota; and the observa-
tion that NEC does not occur in a gnotobiotic setting [10]. Toll-
like receptor 4 expression on enterocytes is necessary for disease
to occur [11], and may explain why its onset is inversely propor-
tional to gestational age at birth. No single organism has been
consistently implicated as causing NEC, and it is thought that
abnormal colonization of the GI tract may play a role in path-
ogenesis [7]. This has suggested various probiotic interventions
as possible prophylactic strategies [12].
To capture the evolution of GI microbiota from birth in the rel-
atively small number of infants who develop NEC, we collected al-
most every fecal sample and >100 ﬁelds of daily clinical data from
every baby born at a 2-site tertiary neonatal unit over a 2-year pe-
riod. We used the culture-independent approach afforded by next-
generation sequencing to characterize microbes on the basis of
variation in the domains of the 16S ribosomal RNA (rRNA) gene.
Combined with additional methods, we identiﬁed 2 signiﬁcant sig-
natures associated with future NEC: 1 characterized by an apparent
bloom of Clostridium perfringens, and the other dominated by a
Klebsiella operational taxonomic unit (OTU).
METHODS
Study Population
Infants born before 32 completed weeks of gestation admitted to
an Imperial College Healthcare National Health Service Trust
neonatal intensive care unit (NICU) (St Mary’s Hospital,
Queen Charlotte’s and Chelsea Hospital) between January
2010 and December 2012 were eligible for inclusion in the
study unless considered to be in extremis in the ﬁrst days of
life. The NICU is a tertiary center with approximately 700 admis-
sions per annum. Of the 388 eligible infants, 369 were recruited.
Both hospitals have identical feeding, antibiotic, and antifungal
protocols, and staff members rotate between sites. Probiotics and
H2 receptor antagonists are not used on the unit. Detailed daily
clinical information was collected from the patients’ records.
Ethics Declaration
The study “Deﬁning the Intestinal Microbiota in Premature In-
fants” (ClinicalTrials.gov identiﬁer NCT01102738) was approved
by West London Research Ethics Committee Two, United
Kingdom (reference number 10/H0711/39). Parents gave written
informed consent for their infant to participate in the study.
Sample Collection
We collected almost every fecal sample produced by each par-
ticipant from the point of recruitment until discharge. Samples
were collected by nursing staff from diapers using a sterile spat-
ula, placed in a sterile DNAase-, RNAase-free Eppendorf tube,
stored in a −20°C freezer on the neonatal unit within 2 hours of
collection, and stored at −80°C within 5 days.
Case Deﬁnition, Control Selection, and Clinical Management
An NEC case was deﬁned using the Vermont Oxford Network
criteria [13] and staged according to the Bell modiﬁed staging
criteria [14]. The diagnosis was made by the attending neonatal
consultant and conﬁrmed by an independent neonatologist.
Three control infants (no NEC or bloodstream infection/sepsis
diagnosis during admission) were selected for each NEC Bell
stage 2/3 case based on postnatal age. Where possible, control
infants were subsequently matched by mode of delivery, admis-
sion hospital, and antibiotic use, as these factors are known to
inﬂuence the microbiota [15–18]. Infants with suspected NEC
were similarly paired to a single control infant. As a separate
substudy, each infant with NEC (Bell stage 1, 2, and 3) was in-
dependently matched to a contemporaneous control on the
same site to address the possibility of an outbreak. Investigators
were not involved in clinical care.
Bacterial DNA Extraction
Fecal samples (200 mg) were processed using the FastDNA
SPIN Kit for Soil (MP Biomedicals), incorporating a bead-
beating step for mechanical disruption of cells. We have estab-
lished that this effectively lyses gram-positive and -negative
bacteria in fecal samples (unpublished data). Extractions were per-
formed following the manufacturer’s protocol except that the ﬁnal
elution step was into Tris (10 mM) low-ethylenediaminetetraacetic
acid (0.1 mM) buffer.
Polymerase Chain Reaction Ampliﬁcation and Pyrosequencing of
the V3–V5 Regions of the Bacterial 16S rRNA Gene
The V3–V5 [19] region of bacterial 16S rRNA genes was ampli-
ﬁed from each DNA sample using a primer pair tagged with in-
dividually unique 12-bp error-correcting Golay barcodes [20, 21].
Polymerase chain reaction (PCR) was performed as previously
described, except that the reaction was cycled 35 times to maxi-
mize ampliﬁcation from samples of low DNA concentration [21].
Replicate amplicons were pooled and puriﬁed, and 4 pyrose-
quencing runs were carried out on a 454 Life Sciences GS FLX
(Roche) following the Roche Amplicon Lib-L protocol. Replicate
samples were spread over all sequencing runs as internal controls.
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Bioinformatics
Shotgun processed data were denoised using AmpliconNoise
[22] as part of the Quantitative Insights Into Microbial Ecology
version 1.5.0 package [23], followed by chimera removal with
ChimeraSlayer [24]. Sequences were aligned using the SILVA
rRNA database (SSU_REF108) [25] for reference and clustered
at 97% sequence identity using the UCLUST algorithm [26] into
OTUs. Representative sequences were selected and classiﬁed
using the Ribosomal Database Project Classiﬁer [27]. Rarefac-
tion was performed, removing heterogeneity of sequencing
reads per sample.
Statistical Analysis
Case and control patient characteristics were compared using Stu-
dent’s t tests and χ2 tests or Fisher’s exact test where appropriate.
OTUs that were differentially abundant between NEC and control
groups were identiﬁed using logistic regression performed using
the generalized linear model and stepwise algorithm of the R stat-
istical package (version 3.0.2) [28]. Comparisons of OTU count
data were performed using Student’s t tests (unequal variances).
P values <.05 were considered to be signiﬁcant.
Data Availability
16S rRNA amplicon data have been deposited at the European
Nucleotide Archive under accession number PRJEB6345.
Bacterial Culture and Identiﬁcation
An antecedent frozen sample as close as possible to the day of
diagnosis of NEC (D0) from every case and their corresponding
contemporaneous control were selected for culture of both
Clostridium species and Enterobacteriaceae. For isolation of Clos-
tridium species, an alcohol shock method [29] was used to elim-
inate non-spore-forming organisms, and the suspension plated
on Fastidious Anaerobic Agar (Oxoid). Additionally, samples
were inoculated on to CHROMagar (BD) to aid identiﬁcation
of Enterobacteriaceae. All bacterial isolates were identiﬁed byma-
trix-assisted laser desorption/ionization–time of ﬂight using a
Bruker Microﬂex LT (Bruker Daltonics).
Typing and Toxin Multiplexed PCR
Isolates of C. perfringens were analyzed at the Public Health En-
gland Foodborne Pathogens reference service for screening for
the presence of alpha, beta, epsilon, iota, cpe, and beta2toxin
genes using multiplexed PCR. Fluorescent ampliﬁed frag-
ment-length polymorphism (fAFLP) typing was undertaken
to establish (non)-relatedness of isolates.
RESULTS
Patients
Three hundred sixty-nine infants were recruited and 10 928
fecal samples collected. Twenty-eight infants developed NEC
during the study period: 10 with Bell stage 1, 2 with Bell stage
2, and 16 with Bell stage 3. Figure 1 illustrates the distribution of
the cases over the 2 years. Six infants with Bell stage 2/3 were
not included in analysis due to lack of samples (developed
NEC prior to obtaining consent) (n = 2), or inadequate se-
quencing reads (n = 4). Two infants with Bell stage 1 could
not be included due to lack of controls. Table 1 outlines the co-
hort clinical characteristics of Bell stage 2/3 infants (12 cases an-
alyzed, 6 not included in analysis) and controls. Comparisons
are displayed between the 12 cases analyzed and, respectively,
the 6 not included in analysis, and controls. Control infants
turned out to have signiﬁcantly more days not requiring respi-
ratory support, and a different birth hospital, from cases. There
were no demographic differences such as mean birth weight,
gestation at birth, birth hospital, mode of delivery, or antibiotic
use between the Bell stage 2/3 infants who were and were not
included in the analysis. Through their developing NEC prior
to obtaining consent, the average age at diagnosis was lower
in the infants who were not included in the analysis.
454-Pyrosequencing and Initial Data Processing
At least 1 fecal sample per week from the 44 control infants was
sequenced to determine the normal GI microbiota. From each
NEC infant, weekly fecal samples from birth and 8 fecal samples
collected in the 2 weeks (where possible) prior to D0 were char-
acterized. No reduction in defecation frequency was observed in
cases prior to D0. There were 174 and 369 samples successfully
processed from NEC infants and controls, respectively. After
Figure 1. Cumulative cases of necrotizing enterocolitis (NEC) over 24
months. Hatching indicates hospital site and Bell staging. Bar length indi-
cates duration of infant admission on the neonatal unit and circles indicate
date of NEC diagnosis. Asterisked cases were excluded from the analyses
due to lack of samples (n = 2), sequencing data (n = 4), or controls (n = 2).
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Table 1. Summary of Cohort Characteristics: Cases With Necrotizing Enterocolitis Bell Stage 2/3 and Controls
Characteristic
Cases Analyzed
(n = 12)
Cases Not Analyzed
(n = 6) Controls (n = 36)
Demographics
Male 5 (41.7) 3 (50.0) 17 (47.2)
Mean birth weight (IQR), g 845.4 (685.0–898.8) 899.3 (732.5–1033.3) 1005.9 (755.0–1239.5)
Mean gestation at birth (IQR), weeks + days 27 + 0 (25 + 5–28 + 3) 27 + 1 (26 + 5–28 + 1) 27 + 3 (25 + 3–29 + 0)
Mean postnatal age at D0 (IQR), d 27.5 (20.8–37.5)* 7.2 (4.5–10.0)* NA
Mean postnatal age at sample taken closest to D0 (IQR), d 26.0 (19–36.3) NA 24.4 (18.0–34.8)
Birth hospital
Site A 11 (91.7)** 5 (83.3) 21 (58.3)**
Site B 1 (8.3)** 0 (0) 7 (19.4)**
Other 0 (0.0)** 1 (17.7) 8 (22.2)**
Ethnicity
Black 2 (16.7) 2 (33.3) 8 (22.2)
White 5 (41.7) 2 (33.3) 18 (50.0)
Asian 2 (16.7) 1 (16.7) 6 (16.7)
Mixed race 2 (16.7) 1 (16.7) 3 (8.3)
Unknown 1 (8.3) 0 (0) 1 (2.8)
Mode of delivery
Cesarean 7 (58.3) 3 (50.0) 18 (50.0)
Vaginal 5 (41.7) 3 (50.0) 18 (50.0)
Maternal characteristics
Maternal IVAB use at delivery 2 (16.7) 2 (33.3) 11 (30.6)
Maternal PROM 2 (16.7) 2 (33.3) 9 (25.0)
Maternal sepsis/chorioamnionitis 3 (25.0) 2 (33.3) 6 (16.7)
Condition at birth
Mean lowest pH recordeda in the first 24 h (IQR) 7.2 (7.2–7.3) 7.2 (7.1–7.2) 7.2 (7.1–7.3)
Mean lowest base excess recordeda in the first 24 h, (IQR) −5.5 (−6.8 to −2.65) −7.4 (−8.8 to −4.9) −6.3 (−9.1 to −3.5)
Mean APGAR at 5 min (IQR) 7.8 (7.0–9.0) 8.2 (8.0–9.0) 7.4 (7.0–9.0)
Intravenous antibiotic use
Mean No. of d of IVABb during first week of life (IQR) 2.1 (0.8–3.0) 2.2 (0.5–2.8) 2.6 (2.0–3.0)
Mean No. of cumulative d of IVABb use prior to D0 (IQR) 3.7 (1.2–3) 2.8 (2.0–3.8) 3.6 (2.0–4.0)
Feeding regime
Mean No. of d received MEBM prior to D0 (IQR) 22.8 (15.0–30.8) 4.0 (2.3–6.0)*** 25.3 (18.0–33.0)
Mean No. of d received DEBM prior to D0 (IQR) 11.9 (7.5–13.3) 3.7 (0.25–5.5)*** 7.8 (4.0–9.0)
Mean No. of d received formula milk prior to D0 (IQR) 0.7 (0–0) 1.0 (0–0) 0.4 (0–0)
Respiratory support requirement
Mean No. of d requiring ventilation support (HFOV or conventional
ventilation) prior to D0 (IQR)
1.8 (0–2.3) 3.8 (2.0–4.5) 3.3 (0–2.8)
Mean No. of d requiring CPAP (no oxygen), prior to D0 (IQR) 7.2 (1–10.8) 1.5 (0–2.8)*** 8.2 (0–13.8)
Mean No. of d requiring CPAP with supplemental oxygen, prior to D0
(IQR)
16.8 (1.8–26.5) 1.8 (0–2.3)*** 8.2 (0–13.8)
Mean No. of d requiring NP oxygen, prior to D0 (IQR) 1.1 (0–0) 0 (0–0) 2.6 (0–4.0)
Mean No. of d not requiring any respiratory support, prior to D0 (IQR) 0.7 (0–0) 0 (0–0) 4.8 (4.0–10.1)
Presence of PDA 2 (16.7) 2 (33.3) 8 (22.2)
Data are presented as No. (%) unless otherwise specified.
Abbreviations: APGAR, Appearance, Pulse, Grimace, Activity, Respiration; CPAP, continuous positive airway pressure; DEBM, donor-expressed breast milk; D0, day
of NEC diagnosis or postnatal age of matched control; HFOV, high-frequency oscillation ventilation; IQR, interquartile range; IVAB, intravenous antibiotics; MEBM,
maternally expressed breast milk; NA, not applicable; NP, nasal prong; PDA, patent ductus arteriosus; PROM, prolonged rupture of membranes.
a Lowest value recorded from cord/free flowing capillary/arterial/venous blood gas.
b First-line IVAB for suspected early-onset sepsis: co-amoxiclav, or benzylpenicillin and gentamicin (if ex utero transfer); second-line IVAB: vancomycin and
piperacillin-tazobactam.
* P = .0001.
** P = .0001.
*** P < .05: confounded by infants with necrotizing enterocolitis (NEC) not included in the analysis systematically developing NEC at a significantly younger postnatal
age.
392 • CID 2015:60 (1 February) • Sim et al
 at Im
perial College London on M
ay 22, 2015
http://cid.oxfordjournals.org/
D
ow
nloaded from
 
denoising and chimera removal, 2 671 225 reads remained and
were de-multiplexed. The mean number of reads was 4919 per
sample. Sample reads were rareﬁed to 1000, with rarefaction
curves showing this to be sufﬁcient to capture the OTU diver-
sity, as measured by the Shannon diversity index (Supplemen-
tary Figure 1). Singletons (sequences present only once in the
dataset) and OTUs present in only 1 sample were removed.
Bacterial Communities in Control Samples
Themost abundant OTU descriptors wereKlebsiella, Staphylococ-
cus (1), Enterobacteriaceae, Enterococcus, and Biﬁdobacterium.
Figure 2 shows the breakdown of OTUs grouped by postnatal
week and mode of delivery. To determine whether the factors
of day of sampling, delivery mode, and birth hospital needed
to be controlled for, logistic regression was used to test for
Figure 2. Bacterial community structure in control infants by postnatal week and mode of delivery. Data were generated using 1 sample per week from
control infants using mean number of reads. When the same descriptive label (genus, family) is attached to >1 operational taxonomic unit (OTU; deﬁned by
97% sequence similarity), these are numbered sequentially; no OTUs are combined.
Figure 3. Bacterial communities in necrotizing enterocolitis (NEC) infant samples collected closest to the day of diagnosis of NEC (D0), and their matched
controls. Samples are categorized along the x-axis. Color intensity indicates the number of rareﬁed reads from each operational taxonomic unit (OTU) that is
found in a sample, as shown by the colored bar. Mean bacterial community diversity was not found to differ signiﬁcantly between NEC and control infant
samples.
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associations, allowing all 3 variables to be potential factors. Five
OTUs were found to be correlated over time; there was
an increase in Biﬁdobacterium and Klebsiella (P = .009 and
P = .02, respectively), and a decrease in both Staphylococcus
(1) and Staphylococcus (2) and Streptococcus (1) (P < .0001,
P = .03, and P = .04, respectively). Vaginal delivery was found
to be associated with Enterobacteriaceae and Clostridium (2)
OTUs (P = .0009 and P = .04, respectively) and cesarean deliv-
ery with Clostridium (1) (P = .02). Aweaker association was also
found between the Enterobacteriaceae OTU and birth outside
sites A and B (P = .05). See Supplementary Figure 2 for com-
plete sequencing data.
Bacterial Communities in NEC Samples
In line with other published studies, our main analyses were
performed on conﬁrmed cases of NEC (Bell stage 2/3); suspect-
ed NEC cases were analyzed separately. The most abundant
OTUs in samples collected closest to D0 in NEC Bell stage
2/3 cases (n = 12) were Klebsiella, Clostridium (1), Staphylococ-
cus (1), and Enterococcus (Figure 3). We sought differences in
OTU abundance of these samples compared with correspond-
ing controls (n = 36) using a linear model to correct for clinical
confounders. Models were constructed for each of the top 13
OTUs (95% of the dataset reads) to determine whether clinical
factors shown in Table 1 and/or case/control status of the
samples correlate with read numbers. After correcting for con-
founding factors, the OTU Clostridium (1) was signiﬁcantly as-
sociated with cases (P = .006) (mean = 135 reads in cases, 26 in
controls). High levels (350 reads) of this OTU were also found
in 1 of the 8 suspected NEC infants, and 1 of their controls.
Logistic Regression Analysis
Logistic regression was used to identify factors discriminating
between the 12 Bell stage 2/3 case samples and the 36 control
samples.
By univariate analysis including as variables the top 13 OTUs
and a range of clinical characteristics (Table 1), we identiﬁed the
number of Clostridium (1) OTU reads and days of continuous
positive airway pressure (CPAP) oxygen as signiﬁcant discrimi-
nators (Clostridium (1) OTU reads, based on the mean number
of reads [135] in the NEC Bell stage 2/3 infants prior to diagnosis:
odds ratio [OR], 2.5 [95% conﬁdence interval {CI}, 1.2–5.2],
P = .02; days of CPAP oxygen, based on a 7-day requirement
in cases: OR, 1.5 [95% CI, 1.1–2.3], P = .04). In a multivari-
ate analysis including all clinical variables, OTUs were added
in turn, interaction with clinical factors was allowed, and the
single OTU most improving the model was retained. Iteration
with further OTUs was repeated until the model no longer
improved.
The resulting model consisted of 4 terms, 2 of which were
signiﬁcant. The ﬁrst signiﬁcant term was the number of
Clostridium (1) OTU reads, with an adjusted OR of 6.2 (95%
CI, 1.8–21.7; P = .004). The second signiﬁcant term was an in-
teraction between the number of Klebsiella OTU reads and
number of days the infant required CPAP oxygen prior to diag-
nosis. Based on the mean number of reads (559) found in the
NEC Bell stage 2/3 infants and a 7-day requirement of CPAP
oxygen, the adjusted OR was 4.6 (95% CI, 1.2–17.0; P = .02).
The relationship of the interactive term is explored in Fig-
ure 4. The risk factor associated with the Clostridium (1)
OTU reads is shown to be independent of days requiring
CPAP oxygen, reﬂected in the model by remaining an individ-
ual term. Cases were therefore deﬁned according to which term
contributed most strongly to indicate NEC, resulting in 4 cases
of “Clostridium-associated” NEC and 7 of “Klebsiella OTU-
associated” NEC. In these 7 cases, the samples closest to diagno-
sis had a higher abundance ofKlebsiellaOTU reads (mean = 870)
than did control samples matched to these cases (mean = 450)
(P < .0001). This dichotomy is seen in Figure 5 where the groups
of cases display very different time courses. The ﬁnal case (N19)
satisﬁed neither criterion. We found no evidence for different
NEC syndromes in our cohort of “Clostridium-associated”
and “Klebsiella OTU-associated” patients.
NEC Screening Criteria
Using the 2 signiﬁcant factors above, a risk score for each of the
NEC dichotomies was calculated for all samples from the 36
controls and the samples prior to diagnosis for the 12 cases.
Figure 4. Relationship between Klebsiella operational taxonomic unit
(OTU) reads and days of continuous positive airway pressure (CPAP) oxygen
requirement by quartiles. Black circles indicate “Clostridium-associated”
necrotizing enterocolitis (NEC); black X’s indicate “Klebsiella OTU-associated”
NEC. Control (white circles) and “Clostridium-associated” NEC samples are
evenly spread over the quartiles. In contrast, “Klebsiella OTU-associated”
NEC samples cluster above the third quartile.
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Calculated thresholds allowed correct classiﬁcation of 10 of 12
cases and 25 of 36 control infants (sensitivity 0.83, speciﬁcity
0.69). The misclassiﬁed cases both occurred in the ﬁrst week
of life. The “Clostridium-associated” NEC cases were determined
to be at risk an average of 5 days (standard deviation [SD], 5
days) prior to diagnosis, and “Klebsiella OTU-associated”
NEC cases an average of 12 days (SD, 6 days) days prior to di-
agnosis. These presymptomatic high risk periods are reﬂected in
the raw OTU data; the Clostridium (1) OTU was seen to in-
crease signiﬁcantly in the week preceding diagnosis (P = .004)
in case samples, whereas the Klebsiella OTU remained at high
levels in the 2 weeks prior to diagnosis.
These screening criteria were then tested on the Bell stage 1
infants, an extremely heterogenous group (only 1 of the babies
went on to develop conﬁrmed NEC). Two of 8 of the Bell stage 1
infants were classiﬁed as cases, and 1 control infant was
misclassiﬁed.
Identiﬁcation of Clostridium Species
In all samples where the Clostridium (1) OTU was present (as at
least 1% of sequencing reads), C. perfringens was isolated by cul-
ture. Although all C. perfringens isolates were type A, they all
differed from one another by fAFLP typing. Three of the 6 iso-
lates from infants with NEC were additionally found to contain
the beta2 toxin gene. This was not found in any of the isolates
from the 3 control infants (Supplementary Table).
Identiﬁcation of Klebsiella OTU Members
Although pyrosequencing indicated a predominant Klebsiella
OTU, which was often the only Enterobacteriaceae OTU
found, there was no single predominant species isolated on cul-
ture, with Klebsiella pneumoniae, K. oxytoca, Enterobacter cloa-
cae, Enterobacter aerogenes, Escherichia coli, and Serratia
marcescens all being identiﬁed. There was no systematic differ-
ence between samples from cases and controls.
DISCUSSION
Previous studies have focused on identifying single causative
pathogens in NEC, but none have been consistently found.
Here we have demonstrated the presence of 2 separate groups
of NEC infants based on the predominating organisms in the
microbiota prior to diagnosis: C. perfringens or the Klebsiella
OTU of Enterobacteriaceae. The microbial signature was the
sole discriminating feature; these were not distinct clinical syn-
dromes. Despite the well-documented clustering of NEC cases
[8]—and there are temporally associated cases in our own
cohort (eg, months 2, 9–10, and 20–22) (Figure 1)—our
study refutes the proposition that any of these cases represented
outbreaks. There is a mixture of “Clostridium-associated” NEC
and “Klebsiella OTU-associated” NEC within each temporally
associated group of cases, and every C. perfringens strain is
distinct.
Clostridium perfringens has been considered as a putative eti-
ological pathogen since NEC was ﬁrst described. In animal
models of NEC, C. perfringens isolated from fecal samples
from premature infants with NEC cause cecal lesions [30]. In
a clinical study, babies with NEC and C. perfringens in their
stool had an earlier onset, more severe clinical course, larger ex-
tent of gangrene, and higher mortality rate [31].The presence of
strains bearing the plasmid-encoded beta2 toxin gene in 3 of the
“Clostridium-associated” NEC cases, but none of the controls
carrying low levels of C. perfringens, is intriguing. The toxin
was originally characterized in a C. perfringens isolate from a
piglet with necrotic enteritis [32], and has been shown to be
Figure 5. Evolution of the fecal microbiota in infants with necrotizing enterocolitis (NEC) Bell stage 2/3. The day of NEC diagnosis is shown at the bottom
right of each bar chart. Cases deﬁned as “Clostridium-associated” NEC are N7, N15, N21, and N26. Cases deﬁned as “Klebsiella OTU-associated” NEC are
N2, N6, N11, N14, N18, N23, and N24. N19 does not ﬁt into either group. Abbreviation: OTU, operational taxonomic unit.
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cytotoxic for human colorectal epithelial (CaCo-2) cells [33].
More research is required to determine whether the beta2
toxin gene is expressed and contributes to NEC.
Our results from the “Klebsiella OTU-associated” NEC in-
fants are consistent with recent NEC microbiota studies that
have found an increase in the proportion of Enterobacteriaceae
and other Proteobacteria in fecal samples taken from infants
around the time of diagnosis [16, 34, 35]. Torrazza et al report
a strong association between a Klebsiella OTU and NEC risk
[16]. From samples containing a similarly labeled OTU in our
study, we isolated multiple different species of Enterobacteria-
ceae, but could not associate NEC with an individual species.
This highlights the necessity to go beyond 16S rRNA character-
ization, particularly when exploring the Enterobacteriaceae
family, where the gene is relatively well conserved [36].
Persistently high levels of facultatively anaerobic Enterobac-
teriaceae in fecal samples are considered to represent a delay in
maturation of the GI microbiota, along with a reduced level of
anaerobes such as Biﬁdobacterium and Bacteroides [37]. Nor-
mally, with time, the GI microenvironment becomes depleted
of oxygen, leading to a predominance of anaerobic organisms
[38]. We speculate that prolonged need for CPAP oxygen
days in our “Klebsiella OTU-associated” NEC infants may
have affected the aerobicity of the gut lumen, allowing organ-
isms such as Enterobacteriaceae to ﬂourish.
This study focused on characterization of the fecal microbiota
associated with NEC and does not address the mechanism of
disease. In light of our ﬁndings, future in vitro work looking
at toxin production of the C. perfringens isolates and potential
virulence factors in the Enterobacteriaceae organisms may con-
tribute toward understanding the pathophysiology. An impor-
tant limitation of the study is that babies who develop NEC in
the ﬁrst week or so of life are systematically less likely to have
provided sequential samples for analysis, and so were underrep-
resented. We might, however, speculate that NEC developing in
these infants is less directly the consequence of the GI microbio-
ta, rather reﬂecting some other complication of early extrauter-
ine life. Of note, case N19, who did not ﬁt into either the
“Clostridium-associated” or “Klebsiella OTU-associated” NEC
groups, developed NEC on day 8 of life.
The 2 microbial signatures identiﬁed in this study constitute
potential biomarkers on which to base quantitative PCR surveil-
lance of fecal samples to identify infants at high risk of NEC,
while the ability to distinguish between “Clostridium-associated”
NEC and “KlebsiellaOTU-associated”NECmay allow early, spe-
ciﬁc treatment.
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